Pharmacology Biochemistry and Behavior 2004-01-01

Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats.

Vilson de Castro Vasques, Melissa Avila de Boer, Felipe Diligenti, Fabrício Brinco, Fabrício Mallmann, Carlos Fernando Mello, Moacir Wajner

Index: Pharmacol. Biochem. Behav. 77(1) , 183-90, (2004)

Full Text: HTML

Abstract

Learning disability is a common feature of patients affected by maple syrup urine disease (MSUD). However, the pathomechanisms underlying learning deficit in this disorder are poorly known. In the present study, we investigated the effect of acute administration of the alpha-keto acids accumulating in MSUD into the hippocampus on the behavior of rats in the open field and in the inhibitory avoidance tasks. Adult male Wistar rats received intrahippocampal injections of alpha-ketoisocaproic acid (KIC, 8 micromol), alpha-ketoisovaleric acid (KIV, 5 micromol), alpha-keto-beta-methylvaleric acid (KMV, 5 micromol), or NaCl (8 micromol) (controls) immediately after or 10 min before training. Testing session was performed 24 h later. Posttraining administration of the keto acids had no effect on learning in the open-field task. In contrast, pretraining administration of KIV and KMV impaired habituation in the open field. Similarly, pretraining administration of KIC, KIV, and KMV affected rat performance in the inhibitory avoidance task, suggesting disruption of acquisition. The results indicate that the alpha-keto acids accumulating in MSUD induce learning deficits in aversive and nonaversive tasks. We therefore suggest that these findings may be related to the psychomotor delay/mental retardation observed in MSUD, and may indicate the contribution of increased brain concentrations of these organic acids to the pathophysiology of the neurological dysfunction of MSUD patients.

Related Compounds

Structure Name/CAS No. Articles
sodium 3-methyl-2-oxovalerate Structure sodium 3-methyl-2-oxovalerate
CAS:3715-31-9
Sodium 3-methyl-2-oxobutanoate Structure Sodium 3-methyl-2-oxobutanoate
CAS:3715-29-5